nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0705	0.123	CbGbCtD
Sitaxentan—CYP2C19—Dapsone—systemic lupus erythematosus	0.0604	0.106	CbGbCtD
Sitaxentan—CYP2C9—Dapsone—systemic lupus erythematosus	0.0502	0.0878	CbGbCtD
Sitaxentan—CYP2C19—Prednisone—systemic lupus erythematosus	0.0419	0.0732	CbGbCtD
Sitaxentan—CYP2C19—Cyclosporine—systemic lupus erythematosus	0.0397	0.0694	CbGbCtD
Sitaxentan—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0334	0.0584	CbGbCtD
Sitaxentan—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.033	0.0577	CbGbCtD
Sitaxentan—CYP3A4—Dapsone—systemic lupus erythematosus	0.0292	0.051	CbGbCtD
Sitaxentan—CYP2C19—Dexamethasone—systemic lupus erythematosus	0.0261	0.0457	CbGbCtD
Sitaxentan—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0253	0.0442	CbGbCtD
Sitaxentan—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0253	0.0442	CbGbCtD
Sitaxentan—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.0217	0.038	CbGbCtD
Sitaxentan—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0217	0.038	CbGbCtD
Sitaxentan—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0214	0.0375	CbGbCtD
Sitaxentan—CYP2C9—cardial valve—systemic lupus erythematosus	0.0208	0.34	CbGeAlD
Sitaxentan—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.0203	0.0355	CbGbCtD
Sitaxentan—CYP3A4—Prednisone—systemic lupus erythematosus	0.0202	0.0354	CbGbCtD
Sitaxentan—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.0192	0.0335	CbGbCtD
Sitaxentan—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.0126	0.0221	CbGbCtD
Sitaxentan—EDNRB—Prostaglandin Synthesis and Regulation—ANXA3—systemic lupus erythematosus	0.00605	0.163	CbGpPWpGaD
Sitaxentan—CYP2C19—urine—systemic lupus erythematosus	0.00579	0.0946	CbGeAlD
Sitaxentan—CYP2C9—urine—systemic lupus erythematosus	0.00449	0.0734	CbGeAlD
Sitaxentan—EDNRA—Prostaglandin Synthesis and Regulation—ANXA3—systemic lupus erythematosus	0.00433	0.117	CbGpPWpGaD
Sitaxentan—EDNRB—cortex of kidney—systemic lupus erythematosus	0.00378	0.0618	CbGeAlD
Sitaxentan—CYP3A4—urine—systemic lupus erythematosus	0.00342	0.056	CbGeAlD
Sitaxentan—EDNRB—tendon—systemic lupus erythematosus	0.00313	0.0512	CbGeAlD
Sitaxentan—EDNRA—cortex of kidney—systemic lupus erythematosus	0.00312	0.0511	CbGeAlD
Sitaxentan—CYP2C19—blood plasma—systemic lupus erythematosus	0.00302	0.0494	CbGeAlD
Sitaxentan—EDNRB—lung—systemic lupus erythematosus	0.00275	0.045	CbGeAlD
Sitaxentan—EDNRA—tendon—systemic lupus erythematosus	0.00259	0.0424	CbGeAlD
Sitaxentan—CYP2C9—blood plasma—systemic lupus erythematosus	0.00234	0.0383	CbGeAlD
Sitaxentan—EDNRA—lung—systemic lupus erythematosus	0.00227	0.0372	CbGeAlD
Sitaxentan—CYP3A4—blood plasma—systemic lupus erythematosus	0.00179	0.0292	CbGeAlD
Sitaxentan—EDNRB—Prostaglandin Synthesis and Regulation—PRL—systemic lupus erythematosus	0.00162	0.0437	CbGpPWpGaD
Sitaxentan—EDNRA—Prostaglandin Synthesis and Regulation—PRL—systemic lupus erythematosus	0.00116	0.0313	CbGpPWpGaD
Sitaxentan—CYP3A4—kidney—systemic lupus erythematosus	0.000809	0.0132	CbGeAlD
Sitaxentan—EDNRB—Endothelin Pathways—NOS3—systemic lupus erythematosus	0.000775	0.0209	CbGpPWpGaD
Sitaxentan—EDNRB—Prostaglandin Synthesis and Regulation—PTGS2—systemic lupus erythematosus	0.000765	0.0206	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide GPCRs—CCR5—systemic lupus erythematosus	0.000596	0.0161	CbGpPWpGaD
Sitaxentan—EDNRA—Endothelin Pathways—NOS3—systemic lupus erythematosus	0.000554	0.015	CbGpPWpGaD
Sitaxentan—EDNRA—Prostaglandin Synthesis and Regulation—PTGS2—systemic lupus erythematosus	0.000547	0.0148	CbGpPWpGaD
Sitaxentan—CYP3A4—nervous system—systemic lupus erythematosus	0.000531	0.00868	CbGeAlD
Sitaxentan—CYP3A4—central nervous system—systemic lupus erythematosus	0.000511	0.00836	CbGeAlD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—P2RY12—systemic lupus erythematosus	0.000476	0.0128	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide GPCRs—CCR5—systemic lupus erythematosus	0.000426	0.0115	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—CXCL12—systemic lupus erythematosus	0.000409	0.011	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—P2RY12—systemic lupus erythematosus	0.000407	0.011	CbGpPWpGaD
Sitaxentan—EDNRB—G alpha (q) signalling events—RASGRP1—systemic lupus erythematosus	0.000386	0.0104	CbGpPWpGaD
Sitaxentan—CYP3A4—Liver X Receptor Pathway—RXRA—systemic lupus erythematosus	0.000376	0.0102	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Other—CCR5—systemic lupus erythematosus	0.000361	0.00975	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—systemic lupus erythematosus	0.000345	0.00932	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—P2RY12—systemic lupus erythematosus	0.00034	0.00919	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—P2RY12—systemic lupus erythematosus	0.00031	0.00837	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—CXCL12—systemic lupus erythematosus	0.000293	0.00789	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—P2RY12—systemic lupus erythematosus	0.000292	0.00787	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—CCR5—systemic lupus erythematosus	0.00028	0.00756	CbGpPWpGaD
Sitaxentan—EDNRA—G alpha (q) signalling events—RASGRP1—systemic lupus erythematosus	0.000276	0.00746	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	0.000274	0.0074	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—C3—systemic lupus erythematosus	0.000274	0.00739	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—JAK1—systemic lupus erythematosus	0.000268	0.00723	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—systemic lupus erythematosus	0.000247	0.00667	CbGpPWpGaD
Sitaxentan—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000247	0.00666	CbGpPWpGaD
Sitaxentan—EDNRB—G alpha (q) signalling events—F2—systemic lupus erythematosus	0.000243	0.00657	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—F2—systemic lupus erythematosus	0.00024	0.00649	CbGpPWpGaD
Sitaxentan—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—systemic lupus erythematosus	0.000225	0.00608	CbGpPWpGaD
Sitaxentan—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000225	0.00607	CbGpPWpGaD
Sitaxentan—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000223	0.00602	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—P2RY12—systemic lupus erythematosus	0.000222	0.00599	CbGpPWpGaD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	0.000219	0.00592	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—F2—systemic lupus erythematosus	0.000218	0.00588	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—CCL2—systemic lupus erythematosus	0.000214	0.00578	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.000209	0.00563	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—CCR5—systemic lupus erythematosus	0.0002	0.00541	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	0.000196	0.0053	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—C3—systemic lupus erythematosus	0.000196	0.00529	CbGpPWpGaD
Sitaxentan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000194	0.00524	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—JAK1—systemic lupus erythematosus	0.000192	0.00517	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.000188	0.00507	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.000184	0.00496	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—systemic lupus erythematosus	0.000176	0.00476	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.000175	0.00473	CbGpPWpGaD
Sitaxentan—EDNRA—G alpha (q) signalling events—F2—systemic lupus erythematosus	0.000174	0.0047	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—F2—systemic lupus erythematosus	0.000172	0.00464	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	0.000161	0.00435	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.000159	0.0043	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	0.000157	0.00424	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—F2—systemic lupus erythematosus	0.000156	0.00421	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—CCL2—systemic lupus erythematosus	0.000153	0.00414	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.000149	0.00403	CbGpPWpGaD
Sitaxentan—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000149	0.00403	CbGpPWpGaD
Sitaxentan—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000148	0.00401	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	0.000144	0.00388	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—CCR5—systemic lupus erythematosus	0.000143	0.00386	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—C3—systemic lupus erythematosus	0.00014	0.00377	CbGpPWpGaD
Sitaxentan—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000136	0.00367	CbGpPWpGaD
Sitaxentan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000135	0.00365	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.000134	0.00363	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.000131	0.00355	CbGpPWpGaD
Sitaxentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000128	0.00346	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—systemic lupus erythematosus	0.000126	0.0034	CbGpPWpGaD
Sitaxentan—Dizziness—Leflunomide—systemic lupus erythematosus	0.000126	0.000382	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.000125	0.00339	CbGpPWpGaD
Sitaxentan—Constipation—Cyclosporine—systemic lupus erythematosus	0.000125	0.000381	CcSEcCtD
Sitaxentan—Pain—Cyclosporine—systemic lupus erythematosus	0.000125	0.000381	CcSEcCtD
Sitaxentan—Dry mouth—Triamcinolone—systemic lupus erythematosus	0.000125	0.00038	CcSEcCtD
Sitaxentan—Renal failure—Methotrexate—systemic lupus erythematosus	0.000125	0.000379	CcSEcCtD
Sitaxentan—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	0.000124	0.000378	CcSEcCtD
Sitaxentan—Anorexia—Hydrocortisone—systemic lupus erythematosus	0.000124	0.000377	CcSEcCtD
Sitaxentan—Stomatitis—Methotrexate—systemic lupus erythematosus	0.000124	0.000376	CcSEcCtD
Sitaxentan—Angiopathy—Prednisone—systemic lupus erythematosus	0.000124	0.000376	CcSEcCtD
Sitaxentan—Conjunctivitis—Methotrexate—systemic lupus erythematosus	0.000123	0.000375	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000123	0.000375	CcSEcCtD
Sitaxentan—Confusional state—Methylprednisolone—systemic lupus erythematosus	0.000123	0.000375	CcSEcCtD
Sitaxentan—Immune system disorder—Prednisone—systemic lupus erythematosus	0.000123	0.000374	CcSEcCtD
Sitaxentan—Malaise—Dexamethasone—systemic lupus erythematosus	0.000123	0.000374	CcSEcCtD
Sitaxentan—Malaise—Betamethasone—systemic lupus erythematosus	0.000123	0.000374	CcSEcCtD
Sitaxentan—EDNRB—GPCR ligand binding—F2—systemic lupus erythematosus	0.000123	0.00331	CbGpPWpGaD
Sitaxentan—Oedema—Triamcinolone—systemic lupus erythematosus	0.000123	0.000373	CcSEcCtD
Sitaxentan—Vertigo—Dexamethasone—systemic lupus erythematosus	0.000123	0.000372	CcSEcCtD
Sitaxentan—Vertigo—Betamethasone—systemic lupus erythematosus	0.000123	0.000372	CcSEcCtD
Sitaxentan—Pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000122	0.000371	CcSEcCtD
Sitaxentan—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.000122	0.000371	CcSEcCtD
Sitaxentan—Infection—Triamcinolone—systemic lupus erythematosus	0.000122	0.00037	CcSEcCtD
Sitaxentan—Hypotension—Hydrocortisone—systemic lupus erythematosus	0.000122	0.00037	CcSEcCtD
Sitaxentan—Infection—Methylprednisolone—systemic lupus erythematosus	0.000122	0.000369	CcSEcCtD
Sitaxentan—Haematuria—Methotrexate—systemic lupus erythematosus	0.000121	0.000368	CcSEcCtD
Sitaxentan—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	0.000121	0.00327	CbGpPWpGaD
Sitaxentan—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	0.000121	0.000367	CcSEcCtD
Sitaxentan—Vomiting—Leflunomide—systemic lupus erythematosus	0.000121	0.000367	CcSEcCtD
Sitaxentan—Insomnia—Prednisolone—systemic lupus erythematosus	0.000121	0.000366	CcSEcCtD
Sitaxentan—Alopecia—Prednisone—systemic lupus erythematosus	0.000121	0.000366	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	0.00012	0.000365	CcSEcCtD
Sitaxentan—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.00012	0.000365	CcSEcCtD
Sitaxentan—Epistaxis—Methotrexate—systemic lupus erythematosus	0.00012	0.000364	CcSEcCtD
Sitaxentan—Rash—Leflunomide—systemic lupus erythematosus	0.00012	0.000364	CcSEcCtD
Sitaxentan—Tachycardia—Triamcinolone—systemic lupus erythematosus	0.00012	0.000364	CcSEcCtD
Sitaxentan—Dermatitis—Leflunomide—systemic lupus erythematosus	0.00012	0.000363	CcSEcCtD
Sitaxentan—Mental disorder—Prednisone—systemic lupus erythematosus	0.00012	0.000363	CcSEcCtD
Sitaxentan—Nausea—Azathioprine—systemic lupus erythematosus	0.000119	0.000363	CcSEcCtD
Sitaxentan—Tachycardia—Methylprednisolone—systemic lupus erythematosus	0.000119	0.000363	CcSEcCtD
Sitaxentan—Headache—Leflunomide—systemic lupus erythematosus	0.000119	0.000361	CcSEcCtD
Sitaxentan—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000119	0.000361	CcSEcCtD
Sitaxentan—Malnutrition—Prednisone—systemic lupus erythematosus	0.000119	0.000361	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.000118	0.00318	CbGpPWpGaD
Sitaxentan—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.000118	0.000358	CcSEcCtD
Sitaxentan—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.000118	0.000358	CcSEcCtD
Sitaxentan—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000116	0.000354	CcSEcCtD
Sitaxentan—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000116	0.000352	CcSEcCtD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	0.000115	0.00311	CbGpPWpGaD
Sitaxentan—Discomfort—Dexamethasone—systemic lupus erythematosus	0.000115	0.000348	CcSEcCtD
Sitaxentan—Discomfort—Betamethasone—systemic lupus erythematosus	0.000115	0.000348	CcSEcCtD
Sitaxentan—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000115	0.000348	CcSEcCtD
Sitaxentan—CYP2C19—Biological oxidations—NAT2—systemic lupus erythematosus	0.000115	0.0031	CbGpPWpGaD
Sitaxentan—Haemoglobin—Methotrexate—systemic lupus erythematosus	0.000115	0.000348	CcSEcCtD
Sitaxentan—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000114	0.000347	CcSEcCtD
Sitaxentan—Pain—Prednisolone—systemic lupus erythematosus	0.000114	0.000346	CcSEcCtD
Sitaxentan—Haemorrhage—Methotrexate—systemic lupus erythematosus	0.000114	0.000346	CcSEcCtD
Sitaxentan—Hepatitis—Methotrexate—systemic lupus erythematosus	0.000114	0.000346	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.000114	0.00308	CbGpPWpGaD
Sitaxentan—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000114	0.000345	CcSEcCtD
Sitaxentan—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000113	0.000344	CcSEcCtD
Sitaxentan—CYP2C19—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.000113	0.00305	CbGpPWpGaD
Sitaxentan—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000113	0.000343	CcSEcCtD
Sitaxentan—Nausea—Leflunomide—systemic lupus erythematosus	0.000113	0.000343	CcSEcCtD
Sitaxentan—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	0.000113	0.000342	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000112	0.000342	CcSEcCtD
Sitaxentan—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000112	0.000341	CcSEcCtD
Sitaxentan—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000112	0.000339	CcSEcCtD
Sitaxentan—Pain—Hydrocortisone—systemic lupus erythematosus	0.000111	0.000338	CcSEcCtD
Sitaxentan—Oedema—Dexamethasone—systemic lupus erythematosus	0.000111	0.000338	CcSEcCtD
Sitaxentan—Oedema—Betamethasone—systemic lupus erythematosus	0.000111	0.000338	CcSEcCtD
Sitaxentan—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000111	0.000337	CcSEcCtD
Sitaxentan—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000111	0.000336	CcSEcCtD
Sitaxentan—Infection—Betamethasone—systemic lupus erythematosus	0.000111	0.000336	CcSEcCtD
Sitaxentan—Infection—Dexamethasone—systemic lupus erythematosus	0.000111	0.000336	CcSEcCtD
Sitaxentan—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	0.00011	0.00298	CbGpPWpGaD
Sitaxentan—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.00011	0.000335	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	0.00011	0.00297	CbGpPWpGaD
Sitaxentan—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.00011	0.000334	CcSEcCtD
Sitaxentan—Visual impairment—Methotrexate—systemic lupus erythematosus	0.00011	0.000334	CcSEcCtD
Sitaxentan—Anaemia—Prednisone—systemic lupus erythematosus	0.00011	0.000333	CcSEcCtD
Sitaxentan—EDNRB—GPCR ligand binding—CCL2—systemic lupus erythematosus	0.000109	0.00295	CbGpPWpGaD
Sitaxentan—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000109	0.000332	CcSEcCtD
Sitaxentan—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000109	0.000332	CcSEcCtD
Sitaxentan—Agitation—Prednisone—systemic lupus erythematosus	0.000109	0.000332	CcSEcCtD
Sitaxentan—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000109	0.000331	CcSEcCtD
Sitaxentan—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000109	0.000331	CcSEcCtD
Sitaxentan—Tachycardia—Betamethasone—systemic lupus erythematosus	0.000109	0.00033	CcSEcCtD
Sitaxentan—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.000109	0.00033	CcSEcCtD
Sitaxentan—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000108	0.000328	CcSEcCtD
Sitaxentan—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000108	0.000328	CcSEcCtD
Sitaxentan—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000108	0.000327	CcSEcCtD
Sitaxentan—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000107	0.000326	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—CXCL12—systemic lupus erythematosus	0.000107	0.00289	CbGpPWpGaD
Sitaxentan—Malaise—Prednisone—systemic lupus erythematosus	0.000107	0.000325	CcSEcCtD
Sitaxentan—Vertigo—Prednisone—systemic lupus erythematosus	0.000107	0.000324	CcSEcCtD
Sitaxentan—Eye disorder—Methotrexate—systemic lupus erythematosus	0.000107	0.000324	CcSEcCtD
Sitaxentan—Tinnitus—Methotrexate—systemic lupus erythematosus	0.000106	0.000323	CcSEcCtD
Sitaxentan—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000106	0.000322	CcSEcCtD
Sitaxentan—Anorexia—Betamethasone—systemic lupus erythematosus	0.000106	0.000322	CcSEcCtD
Sitaxentan—Urticaria—Prednisolone—systemic lupus erythematosus	0.000106	0.000322	CcSEcCtD
Sitaxentan—Cardiac disorder—Methotrexate—systemic lupus erythematosus	0.000106	0.000321	CcSEcCtD
Sitaxentan—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000106	0.000321	CcSEcCtD
Sitaxentan—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000106	0.000321	CcSEcCtD
Sitaxentan—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000105	0.00032	CcSEcCtD
Sitaxentan—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000105	0.000319	CcSEcCtD
Sitaxentan—Pain—Triamcinolone—systemic lupus erythematosus	0.000105	0.000319	CcSEcCtD
Sitaxentan—CYP2C9—Biological oxidations—NAT2—systemic lupus erythematosus	0.000105	0.00282	CbGpPWpGaD
Sitaxentan—Hypotension—Dexamethasone—systemic lupus erythematosus	0.000104	0.000316	CcSEcCtD
Sitaxentan—Hypotension—Betamethasone—systemic lupus erythematosus	0.000104	0.000316	CcSEcCtD
Sitaxentan—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000104	0.000314	CcSEcCtD
Sitaxentan—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000103	0.000314	CcSEcCtD
Sitaxentan—CYP2C9—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.000103	0.00278	CbGpPWpGaD
Sitaxentan—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.000103	0.000313	CcSEcCtD
Sitaxentan—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000103	0.000313	CcSEcCtD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	0.000103	0.00278	CbGpPWpGaD
Sitaxentan—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000103	0.000312	CcSEcCtD
Sitaxentan—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000103	0.000312	CcSEcCtD
Sitaxentan—EDNRA—GPCR ligand binding—CCR5—systemic lupus erythematosus	0.000102	0.00276	CbGpPWpGaD
Sitaxentan—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000101	0.000307	CcSEcCtD
Sitaxentan—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000101	0.000306	CcSEcCtD
Sitaxentan—Alopecia—Methotrexate—systemic lupus erythematosus	0.000101	0.000306	CcSEcCtD
Sitaxentan—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000101	0.000306	CcSEcCtD
Sitaxentan—Insomnia—Betamethasone—systemic lupus erythematosus	0.000101	0.000306	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.0001	0.000305	CcSEcCtD
Sitaxentan—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.0001	0.000305	CcSEcCtD
Sitaxentan—EDNRA—GPCR ligand binding—C3—systemic lupus erythematosus	0.0001	0.0027	CbGpPWpGaD
Sitaxentan—Discomfort—Prednisone—systemic lupus erythematosus	9.99e-05	0.000303	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	9.99e-05	0.0027	CbGpPWpGaD
Sitaxentan—Mental disorder—Methotrexate—systemic lupus erythematosus	9.99e-05	0.000303	CcSEcCtD
Sitaxentan—Malnutrition—Methotrexate—systemic lupus erythematosus	9.93e-05	0.000301	CcSEcCtD
Sitaxentan—Hypersensitivity—Prednisolone—systemic lupus erythematosus	9.83e-05	0.000299	CcSEcCtD
Sitaxentan—Dyspepsia—Dexamethasone—systemic lupus erythematosus	9.8e-05	0.000298	CcSEcCtD
Sitaxentan—Dyspepsia—Betamethasone—systemic lupus erythematosus	9.8e-05	0.000298	CcSEcCtD
Sitaxentan—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	9.79e-05	0.000297	CcSEcCtD
Sitaxentan—Urticaria—Triamcinolone—systemic lupus erythematosus	9.75e-05	0.000296	CcSEcCtD
Sitaxentan—Urticaria—Methylprednisolone—systemic lupus erythematosus	9.73e-05	0.000295	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—TLR9—systemic lupus erythematosus	9.71e-05	0.00262	CbGpPWpGaD
Sitaxentan—Body temperature increased—Triamcinolone—systemic lupus erythematosus	9.7e-05	0.000295	CcSEcCtD
Sitaxentan—Dizziness—Cyclosporine—systemic lupus erythematosus	9.7e-05	0.000294	CcSEcCtD
Sitaxentan—Oedema—Prednisone—systemic lupus erythematosus	9.69e-05	0.000294	CcSEcCtD
Sitaxentan—Decreased appetite—Dexamethasone—systemic lupus erythematosus	9.68e-05	0.000294	CcSEcCtD
Sitaxentan—Decreased appetite—Betamethasone—systemic lupus erythematosus	9.68e-05	0.000294	CcSEcCtD
Sitaxentan—Infection—Prednisone—systemic lupus erythematosus	9.63e-05	0.000292	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	9.61e-05	0.000292	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	9.61e-05	0.000292	CcSEcCtD
Sitaxentan—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	9.6e-05	0.000292	CcSEcCtD
Sitaxentan—Fatigue—Dexamethasone—systemic lupus erythematosus	9.6e-05	0.000291	CcSEcCtD
Sitaxentan—Fatigue—Betamethasone—systemic lupus erythematosus	9.6e-05	0.000291	CcSEcCtD
Sitaxentan—Pain—Dexamethasone—systemic lupus erythematosus	9.52e-05	0.000289	CcSEcCtD
Sitaxentan—Pain—Betamethasone—systemic lupus erythematosus	9.52e-05	0.000289	CcSEcCtD
Sitaxentan—Nervous system disorder—Prednisone—systemic lupus erythematosus	9.51e-05	0.000289	CcSEcCtD
Sitaxentan—Tachycardia—Prednisone—systemic lupus erythematosus	9.46e-05	0.000287	CcSEcCtD
Sitaxentan—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	9.46e-05	0.000287	CcSEcCtD
Sitaxentan—Skin disorder—Prednisone—systemic lupus erythematosus	9.42e-05	0.000286	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—P2RY12—systemic lupus erythematosus	9.41e-05	0.00254	CbGpPWpGaD
Sitaxentan—Asthenia—Hydrocortisone—systemic lupus erythematosus	9.35e-05	0.000284	CcSEcCtD
Sitaxentan—Vomiting—Cyclosporine—systemic lupus erythematosus	9.32e-05	0.000283	CcSEcCtD
Sitaxentan—Rash—Cyclosporine—systemic lupus erythematosus	9.24e-05	0.000281	CcSEcCtD
Sitaxentan—Anorexia—Prednisone—systemic lupus erythematosus	9.24e-05	0.000281	CcSEcCtD
Sitaxentan—Dermatitis—Cyclosporine—systemic lupus erythematosus	9.24e-05	0.00028	CcSEcCtD
Sitaxentan—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	9.21e-05	0.00028	CcSEcCtD
Sitaxentan—Headache—Cyclosporine—systemic lupus erythematosus	9.18e-05	0.000279	CcSEcCtD
Sitaxentan—Anaemia—Methotrexate—systemic lupus erythematosus	9.18e-05	0.000279	CcSEcCtD
Sitaxentan—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	9.17e-05	0.000279	CcSEcCtD
Sitaxentan—Feeling abnormal—Betamethasone—systemic lupus erythematosus	9.17e-05	0.000279	CcSEcCtD
Sitaxentan—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	9.09e-05	0.000276	CcSEcCtD
Sitaxentan—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	9.04e-05	0.000275	CcSEcCtD
Sitaxentan—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	9.02e-05	0.000274	CcSEcCtD
Sitaxentan—Rash—Mycophenolate mofetil—systemic lupus erythematosus	9.02e-05	0.000274	CcSEcCtD
Sitaxentan—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	9.01e-05	0.000274	CcSEcCtD
Sitaxentan—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	8.98e-05	0.00242	CbGpPWpGaD
Sitaxentan—Headache—Mycophenolate mofetil—systemic lupus erythematosus	8.96e-05	0.000272	CcSEcCtD
Sitaxentan—Malaise—Methotrexate—systemic lupus erythematosus	8.95e-05	0.000272	CcSEcCtD
Sitaxentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	8.93e-05	0.00241	CbGpPWpGaD
Sitaxentan—Vertigo—Methotrexate—systemic lupus erythematosus	8.92e-05	0.000271	CcSEcCtD
Sitaxentan—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	8.92e-05	0.000271	CcSEcCtD
Sitaxentan—Leukopenia—Methotrexate—systemic lupus erythematosus	8.89e-05	0.00027	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	8.88e-05	0.0024	CbGpPWpGaD
Sitaxentan—Urticaria—Dexamethasone—systemic lupus erythematosus	8.84e-05	0.000269	CcSEcCtD
Sitaxentan—Urticaria—Betamethasone—systemic lupus erythematosus	8.84e-05	0.000269	CcSEcCtD
Sitaxentan—Dizziness—Prednisolone—systemic lupus erythematosus	8.82e-05	0.000268	CcSEcCtD
Sitaxentan—Asthenia—Triamcinolone—systemic lupus erythematosus	8.8e-05	0.000267	CcSEcCtD
Sitaxentan—Body temperature increased—Dexamethasone—systemic lupus erythematosus	8.8e-05	0.000267	CcSEcCtD
Sitaxentan—Body temperature increased—Betamethasone—systemic lupus erythematosus	8.8e-05	0.000267	CcSEcCtD
Sitaxentan—EDNRA—GPCR ligand binding—F2—systemic lupus erythematosus	8.79e-05	0.00237	CbGpPWpGaD
Sitaxentan—Asthenia—Methylprednisolone—systemic lupus erythematosus	8.78e-05	0.000267	CcSEcCtD
Sitaxentan—Insomnia—Prednisone—systemic lupus erythematosus	8.77e-05	0.000266	CcSEcCtD
Sitaxentan—Nausea—Cyclosporine—systemic lupus erythematosus	8.71e-05	0.000264	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—CSK—systemic lupus erythematosus	8.66e-05	0.00234	CbGpPWpGaD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	8.62e-05	0.00233	CbGpPWpGaD
Sitaxentan—Dizziness—Hydrocortisone—systemic lupus erythematosus	8.62e-05	0.000262	CcSEcCtD
Sitaxentan—CYP2C19—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	8.58e-05	0.00232	CbGpPWpGaD
Sitaxentan—Dyspepsia—Prednisone—systemic lupus erythematosus	8.53e-05	0.000259	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—JAK1—systemic lupus erythematosus	8.53e-05	0.0023	CbGpPWpGaD
Sitaxentan—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	8.5e-05	0.000258	CcSEcCtD
Sitaxentan—Chest pain—Methotrexate—systemic lupus erythematosus	8.45e-05	0.000257	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	8.44e-05	0.00228	CbGpPWpGaD
Sitaxentan—Decreased appetite—Prednisone—systemic lupus erythematosus	8.43e-05	0.000256	CcSEcCtD
Sitaxentan—Rash—Prednisolone—systemic lupus erythematosus	8.41e-05	0.000255	CcSEcCtD
Sitaxentan—Dermatitis—Prednisolone—systemic lupus erythematosus	8.4e-05	0.000255	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	8.39e-05	0.000255	CcSEcCtD
Sitaxentan—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	8.38e-05	0.000254	CcSEcCtD
Sitaxentan—Fatigue—Prednisone—systemic lupus erythematosus	8.36e-05	0.000254	CcSEcCtD
Sitaxentan—Headache—Prednisolone—systemic lupus erythematosus	8.36e-05	0.000254	CcSEcCtD
Sitaxentan—Discomfort—Methotrexate—systemic lupus erythematosus	8.35e-05	0.000254	CcSEcCtD
Sitaxentan—Constipation—Prednisone—systemic lupus erythematosus	8.29e-05	0.000252	CcSEcCtD
Sitaxentan—Vomiting—Hydrocortisone—systemic lupus erythematosus	8.28e-05	0.000252	CcSEcCtD
Sitaxentan—Rash—Hydrocortisone—systemic lupus erythematosus	8.22e-05	0.000249	CcSEcCtD
Sitaxentan—Dermatitis—Hydrocortisone—systemic lupus erythematosus	8.21e-05	0.000249	CcSEcCtD
Sitaxentan—Confusional state—Methotrexate—systemic lupus erythematosus	8.17e-05	0.000248	CcSEcCtD
Sitaxentan—Headache—Hydrocortisone—systemic lupus erythematosus	8.16e-05	0.000248	CcSEcCtD
Sitaxentan—Dizziness—Triamcinolone—systemic lupus erythematosus	8.11e-05	0.000246	CcSEcCtD
Sitaxentan—Dizziness—Methylprednisolone—systemic lupus erythematosus	8.1e-05	0.000246	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—CCR5—systemic lupus erythematosus	8.09e-05	0.00218	CbGpPWpGaD
Sitaxentan—Infection—Methotrexate—systemic lupus erythematosus	8.05e-05	0.000244	CcSEcCtD
Sitaxentan—Feeling abnormal—Prednisone—systemic lupus erythematosus	7.99e-05	0.000243	CcSEcCtD
Sitaxentan—Asthenia—Betamethasone—systemic lupus erythematosus	7.99e-05	0.000243	CcSEcCtD
Sitaxentan—Asthenia—Dexamethasone—systemic lupus erythematosus	7.99e-05	0.000243	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	7.97e-05	0.00215	CbGpPWpGaD
Sitaxentan—Nervous system disorder—Methotrexate—systemic lupus erythematosus	7.95e-05	0.000241	CcSEcCtD
Sitaxentan—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	7.93e-05	0.000241	CcSEcCtD
Sitaxentan—Nausea—Prednisolone—systemic lupus erythematosus	7.92e-05	0.000241	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—NCF2—systemic lupus erythematosus	7.92e-05	0.00214	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—C3—systemic lupus erythematosus	7.9e-05	0.00213	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	7.87e-05	0.00213	CbGpPWpGaD
Sitaxentan—Skin disorder—Methotrexate—systemic lupus erythematosus	7.87e-05	0.000239	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—LYN—systemic lupus erythematosus	7.86e-05	0.00212	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—CCL2—systemic lupus erythematosus	7.83e-05	0.00211	CbGpPWpGaD
Sitaxentan—CYP2C9—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	7.82e-05	0.00211	CbGpPWpGaD
Sitaxentan—Vomiting—Triamcinolone—systemic lupus erythematosus	7.8e-05	0.000237	CcSEcCtD
Sitaxentan—Vomiting—Methylprednisolone—systemic lupus erythematosus	7.78e-05	0.000236	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—JAK1—systemic lupus erythematosus	7.75e-05	0.00209	CbGpPWpGaD
Sitaxentan—Nausea—Hydrocortisone—systemic lupus erythematosus	7.74e-05	0.000235	CcSEcCtD
Sitaxentan—Rash—Triamcinolone—systemic lupus erythematosus	7.74e-05	0.000235	CcSEcCtD
Sitaxentan—Dermatitis—Triamcinolone—systemic lupus erythematosus	7.73e-05	0.000235	CcSEcCtD
Sitaxentan—Anorexia—Methotrexate—systemic lupus erythematosus	7.72e-05	0.000235	CcSEcCtD
Sitaxentan—Rash—Methylprednisolone—systemic lupus erythematosus	7.72e-05	0.000234	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—SH2B3—systemic lupus erythematosus	7.71e-05	0.00208	CbGpPWpGaD
Sitaxentan—Dermatitis—Methylprednisolone—systemic lupus erythematosus	7.71e-05	0.000234	CcSEcCtD
Sitaxentan—Urticaria—Prednisone—systemic lupus erythematosus	7.7e-05	0.000234	CcSEcCtD
Sitaxentan—Headache—Triamcinolone—systemic lupus erythematosus	7.69e-05	0.000233	CcSEcCtD
Sitaxentan—Headache—Methylprednisolone—systemic lupus erythematosus	7.67e-05	0.000233	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—CXCL12—systemic lupus erythematosus	7.67e-05	0.00207	CbGpPWpGaD
Sitaxentan—Body temperature increased—Prednisone—systemic lupus erythematosus	7.66e-05	0.000233	CcSEcCtD
Sitaxentan—Diarrhoea—Betamethasone—systemic lupus erythematosus	7.62e-05	0.000231	CcSEcCtD
Sitaxentan—Diarrhoea—Dexamethasone—systemic lupus erythematosus	7.62e-05	0.000231	CcSEcCtD
Sitaxentan—Hypotension—Methotrexate—systemic lupus erythematosus	7.57e-05	0.00023	CcSEcCtD
Sitaxentan—Dizziness—Betamethasone—systemic lupus erythematosus	7.36e-05	0.000224	CcSEcCtD
Sitaxentan—Dizziness—Dexamethasone—systemic lupus erythematosus	7.36e-05	0.000224	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—CCR5—systemic lupus erythematosus	7.34e-05	0.00198	CbGpPWpGaD
Sitaxentan—Insomnia—Methotrexate—systemic lupus erythematosus	7.33e-05	0.000223	CcSEcCtD
Sitaxentan—Nausea—Triamcinolone—systemic lupus erythematosus	7.29e-05	0.000221	CcSEcCtD
Sitaxentan—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	7.28e-05	0.00196	CbGpPWpGaD
Sitaxentan—Nausea—Methylprednisolone—systemic lupus erythematosus	7.27e-05	0.000221	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—IL2RA—systemic lupus erythematosus	7.24e-05	0.00195	CbGpPWpGaD
Sitaxentan—Somnolence—Methotrexate—systemic lupus erythematosus	7.2e-05	0.000219	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—C3—systemic lupus erythematosus	7.18e-05	0.00194	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	7.15e-05	0.00193	CbGpPWpGaD
Sitaxentan—Hypersensitivity—Prednisone—systemic lupus erythematosus	7.14e-05	0.000217	CcSEcCtD
Sitaxentan—Dyspepsia—Methotrexate—systemic lupus erythematosus	7.13e-05	0.000217	CcSEcCtD
Sitaxentan—Vomiting—Betamethasone—systemic lupus erythematosus	7.08e-05	0.000215	CcSEcCtD
Sitaxentan—Vomiting—Dexamethasone—systemic lupus erythematosus	7.08e-05	0.000215	CcSEcCtD
Sitaxentan—Decreased appetite—Methotrexate—systemic lupus erythematosus	7.04e-05	0.000214	CcSEcCtD
Sitaxentan—Rash—Dexamethasone—systemic lupus erythematosus	7.02e-05	0.000213	CcSEcCtD
Sitaxentan—Rash—Betamethasone—systemic lupus erythematosus	7.02e-05	0.000213	CcSEcCtD
Sitaxentan—Dermatitis—Betamethasone—systemic lupus erythematosus	7.01e-05	0.000213	CcSEcCtD
Sitaxentan—Dermatitis—Dexamethasone—systemic lupus erythematosus	7.01e-05	0.000213	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	7e-05	0.000212	CcSEcCtD
Sitaxentan—Fatigue—Methotrexate—systemic lupus erythematosus	6.99e-05	0.000212	CcSEcCtD
Sitaxentan—Headache—Betamethasone—systemic lupus erythematosus	6.97e-05	0.000212	CcSEcCtD
Sitaxentan—Headache—Dexamethasone—systemic lupus erythematosus	6.97e-05	0.000212	CcSEcCtD
Sitaxentan—Asthenia—Prednisone—systemic lupus erythematosus	6.96e-05	0.000211	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—TLR9—systemic lupus erythematosus	6.95e-05	0.00188	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—F2—systemic lupus erythematosus	6.94e-05	0.00187	CbGpPWpGaD
Sitaxentan—Pain—Methotrexate—systemic lupus erythematosus	6.93e-05	0.00021	CcSEcCtD
Sitaxentan—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	6.9e-05	0.00186	CbGpPWpGaD
Sitaxentan—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	6.8e-05	0.00184	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—P2RY12—systemic lupus erythematosus	6.73e-05	0.00182	CbGpPWpGaD
Sitaxentan—Feeling abnormal—Methotrexate—systemic lupus erythematosus	6.68e-05	0.000203	CcSEcCtD
Sitaxentan—Diarrhoea—Prednisone—systemic lupus erythematosus	6.63e-05	0.000201	CcSEcCtD
Sitaxentan—Nausea—Dexamethasone—systemic lupus erythematosus	6.61e-05	0.000201	CcSEcCtD
Sitaxentan—Nausea—Betamethasone—systemic lupus erythematosus	6.61e-05	0.000201	CcSEcCtD
Sitaxentan—Urticaria—Methotrexate—systemic lupus erythematosus	6.44e-05	0.000195	CcSEcCtD
Sitaxentan—CYP2C19—Biological oxidations—RXRA—systemic lupus erythematosus	6.43e-05	0.00174	CbGpPWpGaD
Sitaxentan—Dizziness—Prednisone—systemic lupus erythematosus	6.41e-05	0.000195	CcSEcCtD
Sitaxentan—Body temperature increased—Methotrexate—systemic lupus erythematosus	6.41e-05	0.000195	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	6.36e-05	0.00172	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CXCL12—systemic lupus erythematosus	6.33e-05	0.00171	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—F2—systemic lupus erythematosus	6.3e-05	0.0017	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—JUNB—systemic lupus erythematosus	6.21e-05	0.00168	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CSK—systemic lupus erythematosus	6.19e-05	0.00167	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	6.17e-05	0.00166	CbGpPWpGaD
Sitaxentan—Vomiting—Prednisone—systemic lupus erythematosus	6.16e-05	0.000187	CcSEcCtD
Sitaxentan—Rash—Prednisone—systemic lupus erythematosus	6.11e-05	0.000186	CcSEcCtD
Sitaxentan—Dermatitis—Prednisone—systemic lupus erythematosus	6.11e-05	0.000185	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—JAK1—systemic lupus erythematosus	6.11e-05	0.00165	CbGpPWpGaD
Sitaxentan—Headache—Prednisone—systemic lupus erythematosus	6.07e-05	0.000184	CcSEcCtD
Sitaxentan—Hypersensitivity—Methotrexate—systemic lupus erythematosus	5.97e-05	0.000181	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—RASGRP1—systemic lupus erythematosus	5.9e-05	0.00159	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—RXRA—systemic lupus erythematosus	5.86e-05	0.00158	CbGpPWpGaD
Sitaxentan—Asthenia—Methotrexate—systemic lupus erythematosus	5.81e-05	0.000177	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—CCR5—systemic lupus erythematosus	5.79e-05	0.00156	CbGpPWpGaD
Sitaxentan—Nausea—Prednisone—systemic lupus erythematosus	5.76e-05	0.000175	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—PRL—systemic lupus erythematosus	5.72e-05	0.00154	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	5.7e-05	0.00154	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NCF2—systemic lupus erythematosus	5.67e-05	0.00153	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—C3—systemic lupus erythematosus	5.66e-05	0.00153	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—LYN—systemic lupus erythematosus	5.63e-05	0.00152	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CCL2—systemic lupus erythematosus	5.62e-05	0.00152	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—JAK1—systemic lupus erythematosus	5.55e-05	0.0015	CbGpPWpGaD
Sitaxentan—Diarrhoea—Methotrexate—systemic lupus erythematosus	5.54e-05	0.000168	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—SH2B3—systemic lupus erythematosus	5.52e-05	0.00149	CbGpPWpGaD
Sitaxentan—Dizziness—Methotrexate—systemic lupus erythematosus	5.36e-05	0.000163	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—CCR5—systemic lupus erythematosus	5.26e-05	0.00142	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—IL2RA—systemic lupus erythematosus	5.18e-05	0.0014	CbGpPWpGaD
Sitaxentan—Vomiting—Methotrexate—systemic lupus erythematosus	5.15e-05	0.000156	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—C3—systemic lupus erythematosus	5.14e-05	0.00139	CbGpPWpGaD
Sitaxentan—Rash—Methotrexate—systemic lupus erythematosus	5.11e-05	0.000155	CcSEcCtD
Sitaxentan—Dermatitis—Methotrexate—systemic lupus erythematosus	5.1e-05	0.000155	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—TYK2—systemic lupus erythematosus	5.1e-05	0.00138	CbGpPWpGaD
Sitaxentan—Headache—Methotrexate—systemic lupus erythematosus	5.08e-05	0.000154	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—F2—systemic lupus erythematosus	4.97e-05	0.00134	CbGpPWpGaD
Sitaxentan—Nausea—Methotrexate—systemic lupus erythematosus	4.81e-05	0.000146	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—IL2—systemic lupus erythematosus	4.67e-05	0.00126	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—JAK1—systemic lupus erythematosus	4.58e-05	0.00124	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CXCL12—systemic lupus erythematosus	4.53e-05	0.00122	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—F2—systemic lupus erythematosus	4.51e-05	0.00122	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—JUNB—systemic lupus erythematosus	4.45e-05	0.0012	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CCR5—systemic lupus erythematosus	4.34e-05	0.00117	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL2RA—systemic lupus erythematosus	4.27e-05	0.00115	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—IL2—systemic lupus erythematosus	4.24e-05	0.00115	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—C3—systemic lupus erythematosus	4.24e-05	0.00114	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—RASGRP1—systemic lupus erythematosus	4.22e-05	0.00114	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PRL—systemic lupus erythematosus	4.1e-05	0.00111	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CCL2—systemic lupus erythematosus	4.02e-05	0.00108	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	3.87e-05	0.00104	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—F2—systemic lupus erythematosus	3.72e-05	0.001	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—TYK2—systemic lupus erythematosus	3.65e-05	0.000985	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CD80—systemic lupus erythematosus	3.57e-05	0.000963	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—IL2—systemic lupus erythematosus	3.34e-05	0.000902	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CCL2—systemic lupus erythematosus	3.32e-05	0.000895	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—JAK1—systemic lupus erythematosus	3.28e-05	0.000884	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CCR5—systemic lupus erythematosus	3.1e-05	0.000838	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.06e-05	0.000826	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—IL2—systemic lupus erythematosus	3.04e-05	0.000819	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—C3—systemic lupus erythematosus	3.03e-05	0.000819	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—TYK2—systemic lupus erythematosus	3.01e-05	0.000813	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NOS3—systemic lupus erythematosus	2.96e-05	0.000798	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—F2—systemic lupus erythematosus	2.66e-05	0.000719	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.56e-05	0.000691	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CD80—systemic lupus erythematosus	2.55e-05	0.000689	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL2—systemic lupus erythematosus	2.51e-05	0.000676	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—IL6—systemic lupus erythematosus	2.49e-05	0.000673	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.47e-05	0.000666	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CCL2—systemic lupus erythematosus	2.37e-05	0.000641	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MMP9—systemic lupus erythematosus	2.37e-05	0.00064	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.36e-05	0.000638	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.25e-05	0.000608	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—EP300—systemic lupus erythematosus	2.25e-05	0.000607	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TYK2—systemic lupus erythematosus	2.16e-05	0.000582	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.13e-05	0.000575	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NOS3—systemic lupus erythematosus	2.12e-05	0.000571	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NAT2—systemic lupus erythematosus	1.96e-05	0.000529	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.95e-05	0.000528	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.83e-05	0.000495	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL2—systemic lupus erythematosus	1.79e-05	0.000484	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	1.79e-05	0.000483	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—IL6—systemic lupus erythematosus	1.78e-05	0.000482	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MMP9—systemic lupus erythematosus	1.7e-05	0.000458	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.69e-05	0.000457	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—EP300—systemic lupus erythematosus	1.61e-05	0.000434	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.56e-05	0.000421	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.52e-05	0.000411	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL6—systemic lupus erythematosus	1.47e-05	0.000398	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.42e-05	0.000384	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.4e-05	0.000378	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.4e-05	0.000378	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.28e-05	0.000345	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.23e-05	0.000331	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	1.18e-05	0.000318	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.12e-05	0.000302	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—RXRA—systemic lupus erythematosus	1.1e-05	0.000297	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL6—systemic lupus erythematosus	1.05e-05	0.000285	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.02e-05	0.000275	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	1e-05	0.000271	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	9.3e-06	0.000251	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PPARG—systemic lupus erythematosus	6.94e-06	0.000187	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	6.61e-06	0.000178	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	6.33e-06	0.000171	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALB—systemic lupus erythematosus	6.24e-06	0.000168	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NOS3—systemic lupus erythematosus	5.97e-06	0.000161	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	5.69e-06	0.000154	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PTGS2—systemic lupus erythematosus	5.46e-06	0.000147	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	5.44e-06	0.000147	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	4.98e-06	0.000134	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—EP300—systemic lupus erythematosus	4.54e-06	0.000123	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	4.17e-06	0.000113	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	4.14e-06	0.000112	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	3.75e-06	0.000101	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	3.59e-06	9.69e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	3.28e-06	8.86e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	2.73e-06	7.37e-05	CbGpPWpGaD
